Isolation Technologies acquired by IDEX Corporation

Isolation Technologies, Inc., a leading developer of advanced column hardware and accessories for the high performance liquid chromatography (HPLC) market, has been acquired by IDEX Corporation (NYSE:  IEX). Alan Fullerton, a partner at Mirus Capital Advisors, was the advisor to Isolation Technologies and its shareholders. Cash consideration was just under $30 million, representing a price-to-sales multiple of nearly 3X.

HPLC instruments are used in a variety of analytical chemistry applications, with primary commercial applications including drug discovery and quality control measurements for pharmaceutical and food/beverage testing. Headquartered in Hopedale, MA, Isolation Technologies had annual revenues of approximately $11 million prior to the transaction. Isolation Technologies will be operated as part of IDEX’s Sapphire Engineering business within the company’s Health and Science Technologies segment.

IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety, and other diversified products built to its  customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and the Chicago Stock Exchange under the symbol “IEX”.

About Mirus Capital Advisors

Mirus Capital Advisors provides investment banking solutions to corporate clients in technology, business services, manufacturing, consumer products, health care, and the resort & hospitality industry. Since 1987, Mirus has provided corporate finance advisory services on engagements including mergers, acquisitions, divestitures, recapitalizations ,and valuations. For additional information, visit www.merger.com.